As predicted, afatinib dramatically blocked hEGF-induced phosphorylation of p-EGFR (Y1068), p-AKT (S473) and p-S6 (S235/236) in all the NB cell lines tested (Figures 5A-5B). Here, AKT1 is linked to neuroblastoma.